Aerobic gram-negative bacilli (E. coli, Klebsiella)
Aerobic gram-positive cocci (GBS, enterococci)
Ureaplasma urealyticum and Mycoplasma hominis
Late-onset endometritis microbiology
Chlamydia trachomatis in 1 to 2% of late-onset cases
Gonorrhea (Neisseria gonorrhoeae)
Pathophysiology
Mechanisms of infection
Ascending contamination pathway
Cervical dilation during labor allows vaginal flora access
Labor disrupts cervical mucus barrier
Internal monitoring devices provide conduit
Decidual susceptibility
Devitalized decidua supports bacterial growth
Devascularized uterine wall post-cesarean
Blood and devitalized tissue as culture medium
Cesarean-specific mechanisms
Uterine incision creates devitalized tissue
Hematoma formation provides bacterial substrate
Disruption of normal uterine closure mechanism
Complication pathways
Myometritis extension
Invasion beyond decidua into myometrium
Necrotizing myometritis in severe cases
Parametritis and pelvic cellulitis
Extension through broad ligament
Uterine wall perforation risk
Septic pelvic vein thrombophlebitis
Septic thrombosis of ovarian or other pelvic veins
Septic emboli to pulmonary vasculature
Pelvic abscess
Walled-off infection in cul-de-sac or parametrium
Requires drainage rather than antibiotics alone
Therapeutic Considerations
Antibiotic strategy principles
Broad-spectrum polymicrobial coverage essential
Single narrow-spectrum agents (ampicillin alone) insufficient
Must cover aerobic and anaerobic organisms
No oral step-down for uncomplicated cases
Cochrane review (Mackeen 2015): oral antibiotics after IV cure provide no benefit
Reduces total antibiotic exposure and C. difficile risk
Fluoroquinolones generally avoided
Limited anaerobic coverage
Breastfeeding concerns
Emerging resistance patterns
Prevention strategies
Perioperative antibiotic prophylaxis at cesarean
Cefazolin 2 g IV within 60 minutes of incision
Azithromycin 500 mg IV addition reduces endometritis by 50% in unplanned cesarean
Level A evidence for prophylaxis benefit
Reduction of modifiable risk factors
Minimizing unnecessary vaginal examinations
Limiting internal monitoring to indicated cases
Optimal glycemic control in diabetic patients
Evidence-based treatment hierarchy
Clindamycin plus gentamicin remains gold standard
Cochrane review supporting superiority over alternative regimens
94% cure rate documented in large series
Enterococcal coverage step-up at 48 hours if needed
Ampicillin addition for enterococcal gap in first-line regimen
Duration driven by clinical response not fixed interval
Afebrile 24 to 48 hours as endpoint
No benefit from continuing beyond clinical cure
Patient Discharge Instructions
copy discharge instructions
Home care for postpartum uterine infection
Antibiotics as prescribed
In most cases no oral antibiotics needed after IV treatment completion in hospital
If prescribed oral antibiotics, take every dose until finished
Rest and recovery
Light activity only during recovery period
Pelvic rest (no intercourse) until cleared by OB/GYN
Hydration
Drink plenty of fluids especially water
Breastfeeding
Safe to continue breastfeeding during and after treatment
Discuss with your doctor if infant shows changes in feeding or stool
Warning signs — return to emergency immediately
Fever returning after discharge
Worsening lower abdominal or pelvic pain
Heavy vaginal bleeding soaking more than one pad per hour
Foul-smelling vaginal discharge
Wound changes at cesarean incision
Increasing redness, swelling, drainage, or opening of wound
Dizziness, lightheadedness, or feeling faint
Difficulty breathing or chest pain
Leg swelling or calf pain (possible blood clot)
Confusion, severe headache, or difficulty speaking
Follow-up instructions
OB/GYN appointment within 1 to 2 weeks of discharge
Assessment of uterine recovery
Wound check if post-cesarean
Discuss contraception planning if desired
If infection was sexually transmitted type, partner must also be treated
Do not resume intercourse until both partners complete treatment
Breastfeeding and newborn care
Breastfeeding is encouraged and generally safe with standard antibiotic regimens
Notify pediatrician of maternal infection and antibiotic exposure
References
Guidelines and key sources
Primary clinical references
Mackeen AD et al. Antibiotic Regimens for Postpartum Endometritis. Cochrane Database of Systematic Reviews 2015
Gold standard evidence supporting clindamycin plus gentamicin
Established evidence against routine oral step-down antibiotics
Duff P. Infection After Cesarean Delivery. American Journal of Obstetrics and Gynecology 2026
Comprehensive review of pathophysiology, risk factors, and management
Shields AD et al. SMFM Consult Series No. 67: Maternal Sepsis. AJOG 2023
Society for Maternal-Fetal Medicine sepsis criteria and management
Sanchez-Ramos L et al. Prophylactic Antibiotics to Prevent Postcesarean Infection. AJOG 2026
Evidence for azithromycin addition to cefazolin prophylaxis
Supporting references
Bailey P et al. Cefoxitin for Endometritis. Clinical Infectious Diseases 2024
Noninferiority of cefoxitin monotherapy versus traditional regimens
Abu Shqara R et al. Low-Grade Fever During Prolonged ROM and Infectious Outcomes. AJOG 2024
Low-grade intrapartum fever OR 9.0 for subsequent endometritis
Wang X et al. Development and Validation of a Predictive Model for Postpartum Endometritis. PLoS One 2024
Bor N et al. Endometritis Following Pregnancy: Comparative Cohort Study with and without RPOC. JOGC 2025
Lambert KA et al. Antibiotic Recommendations After Postpartum Uterine Exploration. Obstet Gynecol Survey 2023
Coding references
ICD-10 O85 puerperal sepsis
Sepsis following delivery
ICD-10 O86.0 infection of obstetric surgical wound
Wound infection post-cesarean
ICD-10 O86.12 endometritis following delivery
Primary diagnostic code for postpartum endometritis
ICD-10 O88.31 pyemic and septic embolism in the puerperium
Septic pelvic vein thrombophlebitis with emboli
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.